To establish a heterogeneous mixture of tumor cells, HER2-GFP or CD33-DsRed was introduced by lentiviral transduction to HER2/CD33 negative MDA-MB-468 cells (figure 5B). The gene discussed is CD33; the disease is neoplasm.